G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients
- Conditions
- Predicting Chemotherapy Related Toxicity in Elderly Patients
- Registration Number
- NCT04992455
- Lead Sponsor
- Namik Kemal University
- Brief Summary
All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. The suitability of G8, VES-13 and CARG chemotherapy risk assessment tools for elderly cancer patients was investigated.
- Detailed Description
All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. G8, VES-13 and CARG toxicity scores of all participating patients will be determined by two independent investigators before starting chemotherapy. The suitability of these practical chemotherapy risk assessment tools for cancer patients for elderly cancer patients was investigated.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
- Aged ≥65 years
- Localized or metastatic solid carcinoma diagnosed by histology (any type, any stage)
- Starting a new-line (first-line, second-line or third-line) chemotherapy
- Concurrent radiotherapy;
- Simultaneous immunotherapy
- Impaired language
- Cognitive function leading to inability to complete assessments.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method G8 (Geriatric 8) screening tool measurement 15-30 minutes VES-13 (Vulnerable Elders Survey-13) measurement 30-60 minutes CARG (Cancer and Aging Research Group) chemotherapy toxicity score measurement 30-60 minutes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Tekirdağ Namık Kemal University
🇹🇷Tekirdağ, Turkey